TRLV · Trulieve Cannabis Corp. · Documents

Aug 6

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $303.44M ▲ 7.7% Net loss $11.98M Diluted EPS -$0.04

Jun 13

Current report 8-K Events of Jun 12

Director or officer change, or executive pay, Shareholder vote results

May 9

Current report 8-K

Financial results, Regulation FD disclosure

May 9

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $297.62M ▲ 4.3% Net loss $24.52M Diluted EPS -$0.16

Apr 30

Annual report to holders ARS

Annual report to holders

Apr 30

Proxy statement DEFA14A

Proxy statement

Apr 29

Proxy statement DEF 14A

Proxy statement

Apr 23

Current report 8-K Events of Apr 17

Director or officer change, or executive pay

Mar 29

Current report 8-K Events of Mar 25

Change of auditor

Feb 29

Current report 8-K

Financial results, Regulation FD disclosure

Feb 29

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $1.13B ▼ 7.3% Net loss $533.14M Diluted EPS -$2.28

Jan 18

Current report 8-K Events of Jan 17

Director or officer change, or executive pay, Regulation FD disclosure

Dec 22

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Dec 1

Current report 8-K

Other events

Nov 9

Current report 8-K

Financial results, Regulation FD disclosure

Nov 9

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $275.21M ▼ 6.8% Net loss $25.84M Diluted EPS -$0.12

Nov 8

Current report 8-K

Other events

Oct 13

Current report 8-K

Regulation FD disclosure

Sep 21

Current report 8-K

Regulation FD disclosure

Aug 9

Current report 8-K

Financial results, Regulation FD disclosure

Aug 9

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $281.8M ▼ 10.2% Net loss $406.87M Diluted EPS -$1.80

Jul 21

Current report 8-K Events of Jul 20

Director or officer change, or executive pay, Regulation FD disclosure

Jun 20

Current report 8-K Events of Jun 14

Director or officer change, or executive pay, Shareholder vote results

Jun 20

Current report 8-K Events of Jun 18

Director or officer change, or executive pay, Regulation FD disclosure

May 10

Current report 8-K

Financial results, Regulation FD disclosure

May 10

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $289.09M ▼ 9.0% Net loss $65.63M Diluted EPS -$0.34

May 1

Proxy statement DEF 14A

Proxy statement

May 1

Current report 8-K Events of Apr 26

Financial results, Regulation FD disclosure

May 1

Annual report to holders ARS

Annual report to holders

May 1

Proxy statement DEFA14A

Proxy statement

Apr 5

Annual report 10-K/A FY2021, ended Dec 31

Annual report for FY2021

Revenue $938.39M ▲ 79.9% Net income $17.45M ▼ 72.3% Diluted EPS $0.12 ▼ 77.4%

Apr 5

Current report 8-K

Other events

Mar 8

Annual report 10-K/A FY2021, ended Dec 31

Annual report for FY2021

Revenue $938.39M ▲ 79.9% Net income $17.45M ▼ 72.3% Diluted EPS $0.12 ▼ 77.4%

Mar 8

Current report 8-K

Financial results, Regulation FD disclosure

Mar 8

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.24B ▲ 32.2% Net loss $252.73M Diluted EPS -$1.06

Feb 24

Late filing notice NT 10-K

Late filing notice

Jan 13

Current report 8-K Events of Jan 10

Director or officer change, or executive pay

Dec 21

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Nov 9

Current report 8-K

Financial results, Regulation FD disclosure

Nov 9

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $300.79M ▲ 34.2% Net loss $115.07M Diluted EPS -$0.41

Aug 10

Current report 8-K

Financial results, Regulation FD disclosure

Aug 10

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $320.28M ▲ 48.9% Net loss $24.02M Diluted EPS -$0.12

Jul 8

Registration statement S-3ASR

Registration statement

Jun 10

Current report 8-K Events of Jun 8

Shareholder vote results

May 24

Current report 8-K/A Events of Mar 31

Director or officer change, or executive pay

May 12

Current report 8-K

Financial results, Regulation FD disclosure

May 12

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $318.35M ▲ 64.2% Net loss $32.48M Diluted EPS -$0.17

Apr 28

Proxy statement DEF 14A Meeting Jun 17, 2022

Proxy statement

Apr 28

Proxy statement DEFA14A

Proxy statement

Apr 5

Current report 8-K Events of Mar 31

Director or officer change, or executive pay